World Crypto Conference Founders Re-Engage

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
31
World Crypto Conference Founders Re-Engage CryptoCurrencyWire to Heighten Awareness of EVOLV’s Global Events

NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire --  CryptoCurrencyWire   (“CCW”), a multifaceted financial news and publishing company, is pleased to announce it has been re-engaged by the founders of World Crypto Conference to serve as the official newswire for the full slate of global blockchain industry events hosted by EVOLV throughout 2019.

On the heels of the wildly successful first annual World Crypto Conference, which took place in Las Vegas, Nevada, organizers of the event recently announced the launch of EVOLV, a premier production company dedicated to offering the world’s most immersive and experiential crypto community gatherings. EVOLV’s lineup of 2019 events will include HODL Rally , the world’s first blockchain supercar rally event; Barcelona Blockchain Summit ; and World Crypto Conference in Las Vegas.

“We were very impressed with the multi-dimensional outreach strategy executed by CryptoCurrencyWire and its affiliated brands for our inaugural World Crypto Conference event last October,” said Adam Williams, CEO of EVOLV. “As we work to promote blockchain technology and digital currency innovation through our global events, it is crucial that we partner with those who can effectively promote these gatherings to the right audiences in this blossoming industry. We are pleased to announce that we have re-engaged CryptoCurrencyWire to partner with us for all of our 2019 events.”

Regarding the re-engagement, Jonathan Keim, communications director of CryptoCurrencyWire, said, “We are thrilled to continue utilizing our resources to support the major expansion taking place in the blockchain community. EVOLV represents a group of masterminds who have proven their ability to produce immersive and interactive experiences that resonate beyond the events themselves, and our team is excited to be part of each one. Following the unforgettable experience at the 2018 World Crypto Conference event in Las Vegas, it is no surprise there are now even more ways for EVOLV’s massive following to stay connected and bring others into the movement.”

EVOLV 2019 event details are as follows:

  • HODL Rally: Standing out as the world's first blockchain-inspired supercar rally, this eight-day networking experience across the European continent will be filled with exciting crypto-themed events taking place from June 29 - July 8, 2019. This unique series will include up to 100 cars and will cover 1,800 miles, eight cities and four countries.
  • Barcelona Blockchain Summit: Taking place July 5, 2019, the Barcelona Blockchain Summit will feature executives from all around Europe showcasing solutions and real-life use cases of blockchain technology. The summit will take over the W Barcelona hotel for a one-of-a-kind crypto and blockchain event and will be the fourth stop along the HODL Rally route. The event will feature top speakers and experts in the crypto and blockchain space, keynote and panel discussions, and exhibitors all backed up to the beautiful Mediterranean Sea.
  • Vegas Blockchain Week: Running from Oct. 26 to Nov. 1, 2019,  Vegas Blockchain Week will bring new advancements, lively debates and discussions regarding opportunity, innovation, change and growth in employment, finance, healthcare, advanced science and the arts. The seven-day event will include summits and gatherings from top digital currency companies, which will be announced in the coming months.
  • World Crypto Conference (WCC): Rounding out Vegas Blockchain Week will be the second annual World Crypto Conference. Following up on a successful debut, the conference experience is back and bigger and better than ever as the industry’s first-ever multi-blockchain developer conference and hackathon. Notable new additions to the conference include WCC DEV CON, expanded World of Mining and World Crypto Poker Tournament experiences, and discussions from thought leaders from enterprise companies.

For more information about EVOLV and its complete roster of events, please visit https://evolv.events/ .

About CryptoCurrencyWire (“CCW”)

CryptoCurrencyWire is a financial news and content distribution company that provides (1) access to a network of wire services via  NetworkWire  to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with  CCW Prime . As a multifaceted organization with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness.

CryptoCurrencyNewsWire is where news, content and information converge via crypto.

For more information, please visit  https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire (CCW) website applicable to all content provided by CCW, wherever published or re-published:  http://CCW.fm/Disclaimer

Corporate Communications: CryptoCurrencyWire (CCW) New York, New York www.CryptoCurrencyWire.com 212.418.1217 Editor@CryptoCurrencyWire.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading